Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaiser Jamil

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Journal of Biomolecular Structure & Dynamics|August 22, 2015
Biased signaling: potential agonist and antagonist of PAR2Kavita Kumari Kakarala, Kaiser Jamil
Avicenna Journal of Medical Biotechnology|February 15, 2013
Thioredoxin system: a model for determining novel lead molecules for breast cancer chemotherapyKaiser Jamil, Sabeena Muhammed Mustafa
Journal of Receptor and Signal Transduction Research|July 10, 2014
Screening of phytochemicals against protease activated receptor 1 (PAR1), a promising target for cancerKavita Kumari Kakarala, Kaiser Jamil
Journal of Hazardous Materials|March 31, 2009
Individual susceptibility and genotoxicity in workers exposed to hazardous materials like leadAbjal Pasha Shaik, Kaiser Jamil
Journal of Biomolecular Structure & Dynamics|November 12, 2014
Protease activated receptor-2 (PAR2): possible target of phytochemicalsKavita Kumari Kakarala, Kaiser Jamil
Journal of Biomolecular Structure & Dynamics|March 8, 2021
Identification of novel allosteric binding sites and multi-targeted allosteric inhibitors of receptor and non-receptor tyrosine kinases using a computational approachKavita Kumari Kakarala, Kaiser Jamil
Cancer Biomarkers : Section a of Disease Markers|June 24, 2010
Thymidylate synthase gene polymorphisms effecting 5-FU response in breast cancer patientsKalyana Kumar, Mohana Vamsy, Kaiser Jamil
Indian Journal of Experimental Biology|March 17, 2006
In vitro cytogenetic studies of cypermethrin on human lymphocytesG Suman, Rambabu Naravaneni, Kaiser Jamil
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 12, 2015
Homology modelling and molecular docking of MDR1 with chemotherapeutic agents in non-small cell lung cancerSyed Subhani, Archana Jayaraman, Kaiser Jamil
Journal of Molecular Graphics & Modelling|September 1, 2014
Structure and putative signaling mechanism of Protease activated receptor 2 (PAR2) - a promising target for breast cancerKavita Kumari Kakarala, Kaiser Jamil, Vinod Devaraji
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Journal of Biomolecular Structure & Dynamics|August 22, 2015
Biased signaling: potential agonist and antagonist of PAR2Kavita Kumari Kakarala, Kaiser Jamil
Avicenna Journal of Medical Biotechnology|February 15, 2013
Thioredoxin system: a model for determining novel lead molecules for breast cancer chemotherapyKaiser Jamil, Sabeena Muhammed Mustafa
Journal of Receptor and Signal Transduction Research|July 10, 2014
Screening of phytochemicals against protease activated receptor 1 (PAR1), a promising target for cancerKavita Kumari Kakarala, Kaiser Jamil
Journal of Hazardous Materials|March 31, 2009
Individual susceptibility and genotoxicity in workers exposed to hazardous materials like leadAbjal Pasha Shaik, Kaiser Jamil
Journal of Biomolecular Structure & Dynamics|November 12, 2014
Protease activated receptor-2 (PAR2): possible target of phytochemicalsKavita Kumari Kakarala, Kaiser Jamil
Journal of Biomolecular Structure & Dynamics|March 8, 2021
Identification of novel allosteric binding sites and multi-targeted allosteric inhibitors of receptor and non-receptor tyrosine kinases using a computational approachKavita Kumari Kakarala, Kaiser Jamil
Cancer Biomarkers : Section a of Disease Markers|June 24, 2010
Thymidylate synthase gene polymorphisms effecting 5-FU response in breast cancer patientsKalyana Kumar, Mohana Vamsy, Kaiser Jamil
Indian Journal of Experimental Biology|March 17, 2006
In vitro cytogenetic studies of cypermethrin on human lymphocytesG Suman, Rambabu Naravaneni, Kaiser Jamil
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 12, 2015
Homology modelling and molecular docking of MDR1 with chemotherapeutic agents in non-small cell lung cancerSyed Subhani, Archana Jayaraman, Kaiser Jamil
Journal of Molecular Graphics & Modelling|September 1, 2014
Structure and putative signaling mechanism of Protease activated receptor 2 (PAR2) - a promising target for breast cancerKavita Kumari Kakarala, Kaiser Jamil, Vinod Devaraji
Pageof 7